Title
Category
Credits
Event date
Cost
  • Opioid Use Disorder (OUD)
  • Pharmacology
  • 10.00 AMA PRA Category 1 Credit
  • 10.00 ANCC
  • 10.00 Association of Social Work Boards (ASWB)
$70.00
Morphine and heroin were first synthesized and used medicinally in the nineteenth century, and recreational and illicit use followed. Historically, heroin dependence has been difficult to treat successfully, with poor outcome being attributed to patient characteristics, environmental factors, and the powerful reinforcing effects of the drug. Agonist-replacement therapy was introduced more than 40 years ago and represented a breakthrough in the management of heroin addiction.
  • Pharmacology
  • Weight Management
  • 15.00 AMA PRA Category 1 Credit
  • 15.00 ANCC
$105.00
Obesity is a chronic, progressive, relapsing, multifactorial disease resulting in metabolic and biomechanical morbidities and premature mortality, and its prevalence has risen to unacceptable levels in the United States and worldwide. Healthy diet, exercise, and behavioral interventions are crucial components of management but are largely unsuccessful in achieving and maintaining weight reduction sufficient to reduce morbidities and prevent premature mortality because the chronic neuroendocrine disease of obesity remains unaddressed.
  • Post-traumatic Stress Disorder (PTSD)
  • Pharmacology
  • 15.00 AMA PRA Category 1 Credit
  • 15.00 ANCC
  • 15.00 Association of Social Work Boards (ASWB)
$105.00
Primary care practitioners treat many civilians and veterans of all ages who exhibit symptoms of PTSD, but many lack the necessary knowledge to identify PTSD and perform differential diagnosis. Also necessary is an understanding of the circumstances that can lead to the development of PTSD and appreciation of the emotional and physical needs of that result from different traumas and different time intervals from the exposure. This course will provide the necessary knowledge and skills to appropriately identify and treat patients with acute stress disorder and PTSD.
  • Alzheimer’s Disease
  • Cognitive Impairment
  • Pharmacology
  • 0.48 AANP Contact Hours
  • 0.48 AANP Pharmacology Contact Hours
  • 0.50 AMA PRA Category 1 Credit
$0.00
Embark on a captivating journey with our distinguished neurology faculty as they delve into the revolutionary world of FDA-approved monoclonal antibody therapies targeting β-amyloid in the treatment of Alzheimer disease (AD). Uncover clinical efficacy, safety nuances, and differences between these newer disease-modifying agents compared to older medications used for AD.
  • Alzheimer’s Disease
  • Cognitive Impairment
  • Pharmacology
  • 1.00 AANP Contact Hours
  • 0.33 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit
$0.00
Catching Alzheimer disease early is critical, yet studies show that 40% of cases may be missed. Join this session to hear a candid discussion between a primary care physician and a geriatric neurologist about how to identify patients with Alzheimer disease and how new and emerging therapies may benefit these patients. 
  • Opioid Use Disorder (OUD)
  • Prescribing: Opioid(s)
  • Pharmacology
  • 0.77 AANP Contact Hours
  • 0.77 AANP Pharmacology Contact Hours
  • 0.75 AMA PRA Category 1 Credit
$0.00
Immerse yourself in a case-based exploration of the complex landscape surrounding opioids and opioid use disorder. In this podcast, you will explore guideline recommendations for safe opioid prescribing, gain insights into diagnosing opioid use disorder, and understand the essential indications for buprenorphine in OUD. Acquire practical knowledge to navigate pain management challenges amidst the opioid epidemic, fostering responsible practices in patient care.
  • Prescribing: Opioid(s)
  • Pharmacology
  • 3.00 AMA PRA Category 1 Credit
  • 3.00 ANCC
$21.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.
  • Pharmacology
  • 0.70 AANP Contact Hours
  • 0.70 AANP Pharmacology Contact Hours
  • 0.75 AMA PRA Category 1 Credit
$0.00
Enhance your knowledge of COVID-19 management for non-hospitalized patients with this comprehensive Q&A. Expert faculty have answered important questions on guideline recommendations for pharmacologic treatments and provided essential insights for navigating potential drug-drug interactions. Add this direct and practical resource to your clinical toolbox and feel equipped to treat COVID-19 in the outpatient setting. 
  • Pharmacology
  • Pain Management
  • 3.50 AANP Contact Hours
  • 1.59 AANP Pharmacology Contact Hours
  • 3.50 AMA PRA Category 1 Credit
$0.00
The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans.
  • Pharmacology
  • Gender-affirming Care
  • LGBTQ
  • 1.00 AANP Contact Hours
  • 1.00 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit
$0.00
This engaging session explores primary care for gender-diverse individuals. Through practical case studies, clinicians will navigate gender-affirming hormone therapies (GAHTs), including the benefits, complications, and comprehensive care strategies for patients. Enhance your expertise in supporting diverse patient populations.

Pages